BioLineRx (NASDAQ:BLRX) Given Hold Rating at Jones Trading
Jones Trading reiterated their hold rating on shares of BioLineRx (NASDAQ:BLRX – Free Report) in a research note published on Wednesday morning, MarketBeat.com reports. Other equities research analysts also recently issued reports about the stock. HC Wainwright upped their price objective on shares of BioLineRx from $9.00 to $26.00 and gave the stock a “buy” […]
